Global Biopolymers has partnered with SS Royal Kit Emirates Investment to form a new bioplastics company based in the United Arab Emirates (UAE).
Based in Dubai, the new company Emirates Biotech said it would focus on the production and marketing of polylactic acid (PLA) biopolymers across the Middle East, Africa and India.
PLA is used in a wide range of applications, such as appliances, electronics, packaging, 3D printing and fibres.
Previously known as Gulf Biopolymers Industries, the new company was planning to build a PLA production facility in the UAE, Emirates Biotech said on 22 July.
“By investing in PLA bioplastics, we are taking a proactive step towards building a more eco-conscious society for generations to come, aligning with the UAE’s vision outlined in the Green Agenda 2030,” SS Royal Kit Emirates Investment’s Shaikh Suhail Ali Saeed Rashed Al-Maktoum said.
Emirates Biotech said it expected commercial operations to start in early 2025 with construction of its first PLA production plant in the UAE starting before 2026.
